AZATHIOPRINE

Clinical Indication

Rheumatological disease

Comments

Full SCA     Request form

Date of classification

October 2013

Orange

Higher risk medicines requiring significant regular monitoring which would be initiated by or at the recommendation of a specialist service which may include mental health services, secondary care, tertiary care, community providers, private providers and GPs with a specialist interest.